Pleomorphic adenoma of the salivary glands: prospective clinicopathologic and flow cytometric study

Head Neck. 1999 Oct;21(7):652-6. doi: 10.1002/(sici)1097-0347(199910)21:7<652::aid-hed10>3.0.co;2-e.

Abstract

Background: Primary surgery is the appropriate treatment for most pleomorphic adenomas of the salivary glands. However, no reliable criteria have been established to predict tumors with aggressive features.

Methods: In 44 patients treated for salivary pleomorphic adenoma, clinicopathologic features and flow cytometric findings were recorded. S-phase fractions were classified as low (0%-1%), intermediate (1.1%-5%), and high (>5%). The relationship between clinicopathologic parameters and flow cytometric DNA analysis was assessed with the Pearson's correlation coefficient.

Results: The mean tumor size was 24.4 mm. Microscopically, myxoid structures predominated in 61.4% of cases. Only five specimens showed high S-phase fractions. All samples were DNA diploid (mean coefficient of variation 3.2%). S-phase fraction and tumor size correlated significantly (r = 0.73, P = 0.003). Two patients with recurrent tumors had high S-phase fractions both on the first resected specimens and at the time of the second operation.

Conclusions: The S-phase fraction may be a valuable predictor of aggressive behavior in salivary pleomorphic adenomas. High S-phase fractions were associated with higher tumor size and a greater tendency to recur.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoma, Pleomorphic / diagnosis
  • Adenoma, Pleomorphic / pathology*
  • Adolescent
  • Adult
  • Chi-Square Distribution
  • DNA, Neoplasm / analysis
  • Female
  • Flow Cytometry
  • Humans
  • Male
  • Prognosis
  • Prospective Studies
  • S Phase
  • Salivary Gland Neoplasms / diagnosis
  • Salivary Gland Neoplasms / pathology*
  • Sensitivity and Specificity

Substances

  • DNA, Neoplasm